Clinical Trial Update: Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating add-on mepolizumab in COPD patients with frequent exacerbations and higher eosinophil counts has completed, and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2025-08-15